New York, NY, March 13, 2023 (Reuters) -- Pfizer Inc struck a $43 billion deal to buy Seagen Inc in the U.S. drugmaker's biggest in a string of acquisitions undertaken after a sales windfall from its COVID-19 products.
Read full article here.
South San Francisco, CA, March 14. 2023 (Business Wire) -- Switch Therapeutics, a preclinical stage biotechnology company pioneering a new way to use RNA science to treat diseases, today announced i
San Diego, CA, March 14, 2023 (Globe Newswire) -- Medical Marijuana, Inc., a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in co
Cambridge, MA, March 6, 2023 (Business Wire) -- Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable anti-tumor response, today
